PrevisEA is a small, self-contained, noninvasive device attached to the patient’s abdomen after surgery. Using proprietary algorithms to detect a highly specific, clinically proven biomarker that is highly correlated with the development of POI. PrevisEA, used in the hours following surgery, is highly accurate in predicting future development of POI. Personalizing postoperative care based upon accurate prediction of POI can:
– Dramatically reduce readmissions due to POI developing at home
– Avoid exacerbation of POI by early feeding
– Reduce postoperative complications
– Reduce length of stay
– Save millions of dollars in total treatment costs and maximize reimbursement